| Carlos E Morales, MD | |
|
855 Mankato Ave, Box 5600, Winona, MN 55987-4868 | |
| (507) 457-4484 | |
| (507) 457-4160 |
| Full Name | Carlos E Morales |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 855 Mankato Ave, Winona, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306863808 | NPI | - | NPPES |
| 34259200 | Other | WI | MA |
| 58G99M0 | Other | MN | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 39837 (Minnesota) | Primary |
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1205887924 PECOS PAC ID: 8123938974 Enrollment ID: O20030507000045 |
News Archive
A type of bacteria plucked from the bottom of the ocean could be put to work neutralizing large amounts of industrial carbon dioxide in the Earth's atmosphere, a group of University of Florida researchers has found.
Asymptomatic left ventricular systolic dysfunction is present in about 5% of general medical inpatients who have at least one risk factor for heart failure, research shows.
All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased the activity of this system and the increased release of building blocks equip the cancer cells with a growth advantage and can render them resistant towards treatment.
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for neuropathic pain associated with post-herpetic neuralgia (PHN) in adults.
A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.
› Verified 1 days ago
| Entity Name | Missoula Community Health Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710165105 PECOS PAC ID: 6709790603 Enrollment ID: O20031114000597 |
News Archive
A type of bacteria plucked from the bottom of the ocean could be put to work neutralizing large amounts of industrial carbon dioxide in the Earth's atmosphere, a group of University of Florida researchers has found.
Asymptomatic left ventricular systolic dysfunction is present in about 5% of general medical inpatients who have at least one risk factor for heart failure, research shows.
All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased the activity of this system and the increased release of building blocks equip the cancer cells with a growth advantage and can render them resistant towards treatment.
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for neuropathic pain associated with post-herpetic neuralgia (PHN) in adults.
A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.
› Verified 1 days ago
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538597703 PECOS PAC ID: 8123938974 Enrollment ID: O20031119000745 |
News Archive
A type of bacteria plucked from the bottom of the ocean could be put to work neutralizing large amounts of industrial carbon dioxide in the Earth's atmosphere, a group of University of Florida researchers has found.
Asymptomatic left ventricular systolic dysfunction is present in about 5% of general medical inpatients who have at least one risk factor for heart failure, research shows.
All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased the activity of this system and the increased release of building blocks equip the cancer cells with a growth advantage and can render them resistant towards treatment.
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for neuropathic pain associated with post-herpetic neuralgia (PHN) in adults.
A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.
› Verified 1 days ago
| Entity Name | Missoula Community Health Services, Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1902990005 PECOS PAC ID: 6709790603 Enrollment ID: O20061104000554 |
News Archive
A type of bacteria plucked from the bottom of the ocean could be put to work neutralizing large amounts of industrial carbon dioxide in the Earth's atmosphere, a group of University of Florida researchers has found.
Asymptomatic left ventricular systolic dysfunction is present in about 5% of general medical inpatients who have at least one risk factor for heart failure, research shows.
All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased the activity of this system and the increased release of building blocks equip the cancer cells with a growth advantage and can render them resistant towards treatment.
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for neuropathic pain associated with post-herpetic neuralgia (PHN) in adults.
A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.
› Verified 1 days ago
| Entity Name | Missoula Community Health Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1902990005 PECOS PAC ID: 6709790603 Enrollment ID: O20190313001297 |
News Archive
A type of bacteria plucked from the bottom of the ocean could be put to work neutralizing large amounts of industrial carbon dioxide in the Earth's atmosphere, a group of University of Florida researchers has found.
Asymptomatic left ventricular systolic dysfunction is present in about 5% of general medical inpatients who have at least one risk factor for heart failure, research shows.
All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased the activity of this system and the increased release of building blocks equip the cancer cells with a growth advantage and can render them resistant towards treatment.
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for neuropathic pain associated with post-herpetic neuralgia (PHN) in adults.
A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carlos E Morales, MD 855 Mankato Ave, Po Box 5600, Winona, MN 55987-4868 Ph: (507) 457-4160 | Carlos E Morales, MD 855 Mankato Ave, Box 5600, Winona, MN 55987-4868 Ph: (507) 457-4484 |
News Archive
A type of bacteria plucked from the bottom of the ocean could be put to work neutralizing large amounts of industrial carbon dioxide in the Earth's atmosphere, a group of University of Florida researchers has found.
Asymptomatic left ventricular systolic dysfunction is present in about 5% of general medical inpatients who have at least one risk factor for heart failure, research shows.
All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased the activity of this system and the increased release of building blocks equip the cancer cells with a growth advantage and can render them resistant towards treatment.
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for neuropathic pain associated with post-herpetic neuralgia (PHN) in adults.
A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.
› Verified 1 days ago
Marc C Dummit, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Mankato Ave, Winona, MN 55987 Phone: 507-457-4160 Fax: 507-457-4160 | |
Christopher Watras, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Mankato Ave, Winona, MN 55987 Phone: 507-454-3650 | |
Christopher J Schubert, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 855 Mankato Avenue, Winona, MN 55987 Phone: 507-457-4484 Fax: 507-457-4160 | |
Charles Kooiker, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Mankato Ave, Winona, MN 55987 Phone: 507-454-3650 | |
Bethany Chapin Corliss Da Rocha, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Mankato Ave, Winona, MN 55987 Phone: 507-454-3650 |